Actomyosin contractility, crucial for several physiological processes including migration, is controlled by the phosphorylation of myosin light chain (MLc). Rho-associated protein kinase (RocK) and Myosin light chain kinase (MLcK) are predominant kinases that phosphorylate MLc. However, the distinct roles of these kinases in regulating actomyosin contractility and their subsequent impact on the migration of healthy and malignant skin cells is poorly understood. We observed that blockade of RocK in healthy primary keratinocytes (HPKs) and epidermal carcinoma cell line (A-431 cells) resulted in loss of migration, contractility, focal adhesions, stress fibres, and changes in morphology due to reduction in phosphorylated MLc levels. in contrast, blockade of MLcK reduced migration, contractile dynamics, focal adhesions and phosphorylated MLC levels of HPKs alone and had no effect on A-431 cells due to the negligible MLCK expression. Using genetically modified A-431 cells expressing phosphomimetic mutant of p-MLc, we show that RocK dependent phosphorylated MLc controls the migration, focal adhesion, stress fibre organization and the morphology of the cells. In conclusion, our data indicate that ROCK is the major kinase of MLC phosphorylation in both HPKs and A-431 cells, and regulates the contractility and migration of healthy as well as malignant skin epithelial cells.
Results
ROCK is crucial for the migration of HPKs and A-431. As a first step towards understanding the role of ROCK and MLCK in the migration of healthy and malignant keratinocytes, we examined the effect of inhibition of ROCK and MLCK on the migration of HPKs and A-431 by using a physiologically relevant 3-dimensional (3D) collagen gel. Y-27632 was used as a ROCK inhibitor, ML-7 as the MLCK inhibitor and Blebbistatin was used for global myosin inhibition. The inhibitors were used at a concentration where they were specific towards their targets and did not result in cell death or cell detachment 13, 25, 26 . The migration of HPKs and A-431 in the collagen gel was examined over a period of 24 hours by live cell imaging in the presence of inhibitors. There was a significant reduction in the migration upon ROCK inhibition in both HPKs (Fig. 1a-c ) and A-431 ( Fig. 1d-f ), resulting in a decrease in both the distance traversed and the velocity of the cells. Inhibition of MLCK reduced the migration of HPKs but not A-431 ( Fig. 1a-f ). This suggests that ROCK is crucial for the 3D migration of both HPKs and A-431 cells. Though MLCK regulates the 3D migration of HPKs, it has no impact on the 3D migration of A-431 cells.
Blockade of ROCK reduces the cellular contractility of both A-431 and HPKs. Cellular contractil-
ity is a crucial property and several fundamental cellular processes, including migration, depend on the ability of the cell to exert contractile force. Since we observed that ROCK and MLCK have distinct roles in regulating the migration of HPKs and A-431, we examined the roles of ROCK and MLCK on the retraction dynamics of HPKs and A-431 cells using the trypsin deadhesion assay 27 . The cells were treated with inhibitors and the retraction of the cells was analysed by time lapse microscopy ( Fig. 2a,b ). Highly contractile cells are expected to retract much faster as compared to less contractile cells. We observed that inhibition of ROCK by Y-27632 resulted in complete loss of cell retraction in both HPKs (Fig. 2c,d ) and A-431 ( Fig. 2e,f) , as evident by the delayed time taken by the cells to retract in the presence of trypsin, indicating disruption of the contractility of both the cell types entirely. Blockade of MLCK resulted in a loss of contractility in HPKs, though no effect was observed in the contractility of A-431 cells. Blebbistatin treatment significantly inhibited the contractility in HPKs and A-431 cells, similar to Y-27632 treatment ( Fig. 2c-f ). These data suggest that ROCK activity is crucial for maintaining the contractility of both HPKs and A-431 cells. MLCK plays a role in regulating contractility in HPKs, but not in A-431 cells.
ROCK controls focal adhesion maturation of HPKs and A-431 cells, whereas MLCK regulates focal adhesion localization and maturation of HPKs alone. Focal adhesion formation is a myosin
driven process and is crucial for migration and cell adhesion. Focal adhesions help convert the contractile forces generated in the cell into traction forces, which helps to pull the cells in the direction of motion 28 . Since we observed that ROCK and MLCK have distinct functions in regulating the contractility of HPKs and A-431, we examined the roles of these kinases on the focal adhesion organization of HPKs and A-431. ROCK blockade by Y-27632 resulted in a significant reduction in both the number and area of focal adhesions in both HPKs (Fig. 3a,b ) and A-431 cells ( Fig. 3c,d) , indicating a complete loss in mature focal adhesions. Blockade of MLCK by ML-7 reduced the number and size of focal adhesions as well as localized the focal adhesions to the periphery of the HPKs (Fig. 3a,b) , with no impact on focal adhesion organization in A-431 cells ( Fig. 3c,d) . In both the cell types, treatment with Blebbistatin resulted in a loss in both number and size of the focal adhesions, similar to Y-27632 treatment ( Fig. 3a-d) . These data indicate that ROCK is the major kinase that regulates the formation of mature focal adhesions in HPKs and A-431 cells.
ROCK regulates actin stress fibres formation in both HPKs and A-431, and MLCK regulates
stress fibre formation in only HPKs. Actin stress fibres are important for the generation of contractile forces along with focal adhesions. We examined the roles of ROCK and MLCK on the organization of actin stress fibres and observed that inhibition of ROCK by Y-27632 treatment resulted in dissociation of the stress fibres and reduction in their numbers in both HPKs (Fig. 4a,b ) and A-431 cells ( Fig. 4c,d ). ML-7 treatment resulted in reduction in number of stress fibres and peripheral actin localization similar to the focal adhesions in HPKs ( Fig. 4a ,b), with no effect on A-431 cells ( Fig. 4c,d ). Blebbistatin treatment led to the dissociation of actin stress fibres in both HPKs and A-431 ( Fig. 4a-d ). These data indicate that ROCK pathway majorly regulates the organization of actin stress fibres in HPKs and A-431 cells. However, MLCK regulates the actin stress fibre formation and organization in HPKs alone.
Morphology of HPKs and A-431 is distinctly regulated by ROCK and MLCK.
We observed that ROCK and MLCK differentially regulate the morphology of the cells as well. Inhibition of ROCK resulted in cells that were larger, more spread and more polar as compared to the vehicle treated cells with the formation of membrane protrusions in both HPKs and A-431. Inhibition of MLCK rendered the HPKs smaller, rounder and less polar but there was no significant change in morphology observed in A-431 cells. Blebbistatin treatment resulted in morphology similar to ROCK inhibition ( Supplementary Fig. 1a-f ). This suggests that ROCK plays a role in regulating cell morphology in HPKs and A-431. However, MLCK has a role in regulating cell morphology in HPKs only.
ROCK and MLCK differentially influence the cortical stiffness of HPKs and A-431. Stiffness of
cells is another biophysical characteristic which is highly correlated with the actin stress fibre organization and cellular morphology. Since ROCK and MLCK inhibition influenced the organization of stress fibres and morphology in HPKs and A-431, the roles of these kinases were examined on cell stiffness by atomic force microscopy (AFM). Cells were treated with the inhibitors and were indented using a pyramid-tipped probe. The elastic moduli of an individual cell were computed from the force curve obtained. It was observed that ROCK inhibition by Y-27632 significantly decreased the cortical stiffness of both HPKs (Fig. 4e ,f) and A-431 ( Fig. 4g,h) , while ML-7 treatment increased the cortical stiffness HPKs alone ( Fig. 4f) . No effect was observed in A-431 cells upon MLCK inhibition (Fig. 4h ). These data indicate that ROCK is crucial in maintaining the cortical stiffness of both HPKs and A-431. www.nature.com/scientificreports www.nature.com/scientificreports/
ROCK is the dominant kinase that phosphorylates MLC in A-431, whereas both ROCK and MLcK have distinct roles in regulating p-MLc in HpKs.
Since we observed that inhibition of ROCK and MLCK had distinct effects on the migration, contractility and focal adhesion organization of HPKs and A-431, we analysed the effect of ROCK and MLCK inhibition on the p-MLC levels in both cell types. p-MLC was examined by immunofluorescence using a primary antibody against the phosphorylated serine residue (S19) on MLC. We observed that blockade of ROCK in HPKs resulted in a notable absence of p-MLC in the actin rich protrusions sites (Fig. 5a , indicated by white arrows), though no effect was seen on the localization in A-431 ( Fig. 5c ). MLCK blockade resulted in localization of p-MLC at the periphery in HPKs (indicated by yellow arrows), while there was no difference in the localization of p-MLC in A-431 upon MLCK inhibition (Fig. 5a,c) . www.nature.com/scientificreports www.nature.com/scientificreports/ Quantification of the p-MLC level was performed by measuring the total corrected fluorescence from the immunofluorescence images. It was observed that ROCK inhibition resulted in significant loss of p-MLC in both HPKs (Fig. 5b ) and A-431 ( Fig. 5d ). While MLCK inhibition also resulted in decreased p-MLC levels in HPKs (Fig. 5b ), no significant difference was observable in A-431 upon MLCK inhibition (Fig. 5d ). To ensure that the ML-7 used was active, different batches of the drug were used and were also tested on HeLa cells. ML-7 treatment www.nature.com/scientificreports www.nature.com/scientificreports/ resulted in a decrease in the p-MLC levels in HeLa cells ( Supplementary Fig. 2a,b ) in line with a previous observation 29 . These data suggest that ROCK, and not MLCK, is the dominant kinase responsible for the phosphorylation of MLC in A-431. Also, both ROCK and MLCK distinctly control the localization and levels of p-MLC in HPKs.
MLCK levels are downregulated in A-431 as compared to HPKs.
Since inhibition of MLCK did not have any effect on the p-MLC levels or any of the cellular characteristics tested in A-431 cells, we wished to examine if the lack of response to ML-7 (MLCK inhibitor) was due to alterations in the levels of MLCK in A-431. We compared the fold change in the mRNA levels of ROCK1 and overall MLCK between HPKs and A-431 by real time PCR. We observed that the mRNA levels of MLCK were downregulated in A-431 cells compared to the HPKs (Fig. 5e ). There was an inconsistent difference in the mRNA levels of ROCK1 between HPKs and A-431 cells, which was not significant (Fig. 5f ). We also compared the relative mRNA expression between ROCK1 and MLCK in HPKs and A-431.We observed that the relative mRNA expression of ROCK1 and MLCK was comparable in HPKs, whereas A-431 cells had a significantly higher level of ROCK as compared to MLCK (Fig. 5g,h) . This indicates that the lack of cellular response to ML-7 treatment is due to the significant downregulation of MLCK in A-431 cells. The significantly higher levels of ROCK solely regulate contractile dynamics in A-431 cells.
phosphorylation of MLc is critical for cell migration and other associated cellular features.
Our results with Y-27632 indicate that ROCK mediated p-MLC activity controls migration and other cellular features such as focal adhesions, stress fibre organization and morphology of A-431 cells. To strengthen our observations that phosphorylation of MLC is the key mediator of migration, we generated genetically modified A-431 cells with phosphomimetic MLC by replacing Ser19 and Thr18 with aspartic acid (DD-MLC-GFP). This mutant will therefore behave as constitutively phosphorylated p-MLC. Since Y-27632 inhibits the phosphorylation on Thr18 and Ser19 of MLC, addition of Y-27632 to cells transfected with DD-MLC-GFP should not have any effect on the migration or other cellular features, if they are regulated by p-MLC. As a control, we generated A-431 cells transfected with wild type MLC (WT-MLC-GFP), where Y-27632 treatment is expected to inhibit the p-MLC activity and migration of these cells, similar to non-transfected cells.
Similar to our observation with non-transfected cells, A-431 cells transfected with WT-MLC-GFP showed reduced migration upon Y-27632 treatment and no change by ML-7 (Fig. 6a,b ). Y-27632 treatment also resulted in reduced focal adhesions, dissociation of stress fibres and more polar cells in A-431 cells transfected with WT-MLC-GFP ( Fig. 6d) In contrast, ROCK inhibition by Y-27632 did not affect the migration (Fig. 6b) or the focal adhesion status, stress fibre formation and morphology of A-431 cells transfected with DD-MLC-GFP (Fig. 6d) , indicating that ROCK mediated phosphorylation of MLC is critical for the migration, focal adhesion formation, stress fibre organization and morphology of A-431 cells. 
Discussion
Our study revealed few interesting observations regarding the role of ROCK and MLCK in regulating the actomyosin machinery, and ultimately the migration of human primary keratinocytes and epidermoid carcinoma cells: (1) ROCK is critical for controlling the biophysical properties (contractility, focal adhesions levels, stress fibre formation) of normal (HPKs) and malignant skin epithelial cells (A-431 cells) and impacts their migration by influencing the p-MLC levels. (2) In contrast, MLCK regulates the biophysical properties and migration of HPKs but does not have significant impact on A-431 cells due to negligible MLCK expression.
We observed that the migration of HPKs in a 3D environment was completely lost by the inhibition of ROCK as well as MLCK. Cell migration is a coordinated process involving the cytoskeleton and adhesion complexes 30 , which is regulated by MLC phosphorylation. Focal adhesions, in tandem with actin stress fibres generate the necessary forces required for the cell to migrate 31 . Focal adhesions are critical for the migration of cells in a dense matrix and reduction in focal adhesions is seen to adversely affect migration of cells in 3D 32 . In this study, Y-27632 treatment resulted in a complete loss of mature focal adhesions, as well as dissociation of actin stress fibres in both HPKs and A-431 cells. Such a cell will not be able to generate sufficient forces necessary for migration, as evident by the lack of retraction dynamics tested by the trypsin deadhesion assay (Fig. 2) and could be a contributing factor as to why Y-27632 treated cells show reduced migration in 3D as compared to the control cells. On the other hand, we observed that ML-7 treatment of HPKs, resulted in a decrease in both number and average area of the focal adhesions, along with a reduction in the stress fibres, which impacted contractility of the cells, resulting in a reduction in 3D migration as well. In contrast, ML-7 treated A-431 cells did not show any significant change in focal adhesions or stress fibres, which ultimately did not affect the 3D migration as well.
Studies have described that a balance of contractile force generation and cytoskeletal remodelling are essential for the efficient migration of cells in a 3D environment 33 . A loss in any of these attributes can impair 3D migration, as evident from the reduction in 3D migration due to the loss of contractile force generation by blockade of ROCK and MLCK in HPKs. Studies have reported that contractile force generation is of paramount importance for migration of cells in 3D 34, 35 . We observed that p-MLC levels, which are crucial for contractile force generation, were also lowered in HPKs treated with both ROCK and MLCK inhibitors, resulting in abrogation in contractility and ultimately, decreased migration in both conditions. While inhibition of ROCK in A-431 cells led to a loss in 3D migration due to reduced p-MLC levels and contractility, MLCK inhibition did not affect these attributes of A-431 cells. This phenomenon seen in A-431 cells is also consistent with a previous study performed on melanoma cell line MDA-MB-453, where MLCK inhibition had no effect on the contractile dynamics of MDA-MB-453 13 . MLCK is known to be highly downregulated in cancer cells at both mRNA and protein levels 29 . We also observed that MLCK mRNA levels were highly downregulated in A-431 cells as compared to HPKs. The loss of MLCK in A-431 could be the major reason why treatment with ML-7 had minimal effects on the contractility and invasion of the malignant cells.
Phosphorylation of MLC by ROCK also regulated the focal adhesion organization and morphology of the cells as previously demonstrated 36 . Treatment of HPKs with ROCK and MLCK inhibitors resulted in the reduction of p-MLC levels, but the localization of p-MLC in the cells had varied effects on the focal adhesion organization as well as morphology of the cells. While ROCK inhibited HPKs showed an increase in polarity due to loss of p-MLC at the edges of the cell, MLCK inhibited cells showed localization of p-MLC in the cell periphery, resulting in rounder cells. The localization of focal adhesions and stress fibres in MLCK inhibited HPKs was also seen to be dependent on the p-MLC localization. Similarly, though there was no effect of MLCK inhibition in A-431, ROCK inhibition resulted in lack of mature focal adhesions, dissociation of stress fibres and highly polar cells due to loss of p-MLC. This was further confirmed when cells transfected with the phosphomimetic mutant of MLC did not show any alterations in focal adhesion organization or morphology as the inhibitors had no effect on the phosphorylation status of the constitutively phosphorylated (phosphomimetic) mutant, indicating that changes in p-MLC due to ROCK and/or MLCK inhibition were indeed responsible for the variations in focal adhesion organization, morphology and ultimately the migration of HPKs and A-431.
We also observed that MLCK and ROCK differentially regulate the stiffness of HPKs and A-431. Inhibition of MLCK significantly increased the cortical stiffness of HPKs, though there was a loss in the number of stress fibres. The increased stiffness could be due to the reduced cell spreading of the HPKs upon inhibition of MLCK, which increased the thickness of the cells. This phenomenon has been previously observed in hepatocytes as well 37 . Also, the presence of actin stress fibres at the cell periphery is known to reinforce cortical stiffness 38 . On the contrary, ROCK inhibition resulted in a significant decrease in the cortical stiffness of HPKs and A-431, due to depolymerisation of actin. The complete dissociation of stress fibres as well as increase in spread area due to the inhibition of ROCK resulted in decreased cortical stiffness, resulting in reduced 3D migration in both the cell types. Similar to the effect seen in this study, we have shown previously that abrogation of ROCK by Y-27632 treatment significantly reduced the stiffness in cancer cells 13 .
Our results from this study demonstrate important differences in the regulation of contractility and 3D migration by ROCK and MLCK between healthy and malignant skin cells. Our in vitro data about the expression levels is also supported by the fact that MLCK is seen to be down regulated in tumor samples of skin malignancies as well, analysed using TCGA database and Xena software ( Supplementary Fig. 3a ). In addition, analysis of the overall survival rate and MLCK expression revealed that low MLCK expression is associated with a slightly poorer prognosis as compared to high MLCK expression ( Supplementary Fig. 3b ). Developing biologics that target ROCK or upregulate MLCK may be of profound value in conditions where aberrant and increased invasion is seen in keratinocytes, such as in pathological conditions like keratinocyte cancers and inflammation. It is also of importance to understand the influence of various upstream and downstream signalling molecules of ROCK in important cellular functions of keratinocytes, including normal and pathogenic conditions such as wound healing, tissue repair, inflammation and cancer. Apart from MLC and MLC phosphatase, ROCK also phosphorylates LIMK, which in turn phosphorylates Cofilin and regulates the actin de-polymerization. Studies have associated 3D migration assay. 24 well plates were treated with 2% glutaraldehyde for 20 minutes and washed thrice with sterile distilled water. Collagen gels (final concentration 1 mg/ml) were prepared using rat tail collagen type I. 1 N NaOH was used to adjust the pH to 7.4. Cell suspensions with appropriate cell density were mixed with the collagen gel and immediately seeded on glutaraldehyde coated wells. The gels were allowed to solidify for 1 hour at 37 °C and were treated by layering media with the treatments (20 μM) on the gels. The cells were imaged using a spinning disc confocal microscope (Zeiss, Germany) under 10X magnification for 24 hours. The migration of the cells was tracked using ImageJ software. trypsin deadhesion assay. The treated cells were washed with 1X DPBS and pre-warmed trypsin (0.25%, 500 μl) was added to the well. Images were captured every 3 seconds till the cells rounded up. The normalized change in area (A) was calculated using the formula:
where A i is cell area at time t = 0, A t is area at time = t, and A f is area at the final time point. The de-adhesion curves were fitted with the Boltzmann equation to obtain the time constants τ 1 and τ 2 : Immunofluorescence. For the p-MLC staining, treated cells were fixed with 4% paraformaldehyde for 20 minutes, permeabilized using 0.1% Triton X-100 for 4 minutes, blocked with 2% BSA for 30 minutes and incubated with anti p-MLC antibody (Invitrogen, USA) (1:100) overnight at 4 °C. The cells were incubated with Alexa Fluor 488 goat anti-rabbit secondary antibody (Invitrogen, USA) and Alexa Fluor 647 Phalloidin for 2 hours. Images were acquired using LSM confocal microscope (Zeiss, Germany) under 63X magnification. The corrected total cell fluorescence (CTCF) obtained after background subtraction from the formula: Integrated cell density -(Mean fluorescence of the background*Area of the cell). For focal adhesion staining, the treated cells were permeabilized using a 1:1 solution of cold 4% paraformaldehyde and 0.1% Triton X-100 solution for 5 minutes on ice. The cells were incubated in 4% paraformaldehyde for 1 minute on ice, washed thrice and blocked with blocking solution (1.5% BSA and 0.1% Triton X-100 in DPBS) for 30 minutes on ice and incubated with anti-vinculin antibody (Invitrogen, USA) overnight. The cells were incubated with Alexa Fluor 488 goat anti-mouse secondary antibody and Alexa Fluor 647 Phalloidin for 2 hours. Images were acquired using LSM confocal microscope (Zeiss, Germany) under 63X magnification. The quantification of the number and size of the focal adhesions was performed using the image processing tools and threshold feature of ImageJ software as previously described 43 .
